5′-N-ethylcarboxamide induces IL-6 expression via MAPKs and NF-κB activation through Akt, Ca2+/PKC, cAMP signaling pathways in mouse embryonic stem cells

Journal of Cellular Physiology

Volumn 219, Issue 3, 2009, Pages 752-759

  Mi, Ok Kim ^a   Min, Hee Kim ^a   Sang, Hun Lee ^a   Han, Na Suh ^a   Yu, Jin Lee ^a   Min, Yong Lee ^a   Ho, Jae Han ^a  

^a Chonnam National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

9 (TETRAHYDRO 2 FURYL)ADENINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; ADENOSINE A2B RECEPTOR; ADENOSINE A3 RECEPTOR; BISINDOLYLMALEIMIDE; CAFFEINE; CALCIUM ION; CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; PROTEIN KINASE C;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; CYTOKINE RELEASE; EMBRYO; EMBRYONIC STEM CELL; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GENE EXPRESSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; BIOLOGICAL MODEL; BIOSYNTHESIS; CALCIUM SIGNALING; CELL CULTURE; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; METABOLISM; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ADENOSINE-5'-(N-ETHYLCARBOXAMIDE); ANIMALS; CALCIUM SIGNALING; CELLS, CULTURED; CYCLIC AMP; EMBRYONIC STEM CELLS; GENE EXPRESSION; INTERLEUKIN-6; MAP KINASE SIGNALING SYSTEM; MICE; MODELS, BIOLOGICAL; NF-KAPPA B; PHOSPHORYLATION; PROTEIN KINASE C; PROTO-ONCOGENE PROTEINS C-AKT; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 64549121573     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21721     Document Type: Article

References (35)

1. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
2. Crisostomo PR, Meldrum DR. 2007. Stem cell delivery to the heart: Clarifying methodology and mechanism. Crit Care Med 35:2654-2656.
3. Crisostomo PR, Wang M, Markel TA, Lahm T, Abarbanell AM, Herrmann JL. 2007. Stem cell mechanisms and paracrine effects: Potential in cardiac surgery. Shock 28:375-383. (Pubitemid 47415247)
4. De Rooij J, Rehmann H, van Triest M, Cool RH, Wittinghofer A, Bos JL. 2000. Mechanism of regulation of the Epac family of cAMP-dependent RapGEFs. J Biol Chem 275:20829-20836. (Pubitemid 30457676)
5. 2b receptors evoke interleukin-8 secretion in humanmast cells. An enprofylline-sensitive mechanism with implications for asthma. J Clin Invest 96:1979-1986.
6. 2b receptor-mediated interleukin-8 production in human mast cells. Mol Pharmacol 55:726-735.
7. Fredholm BB. 1997. Adenosine and neuroprotection. Int Rev Neurobiol 40:259-280. (Pubitemid 126839964)
8. Fredholm BB. 2003. Adenosine receptors as targets for drug development. Drug News Perspect 16:283-289. (Pubitemid 37176216)
9. Fredholm BB, Ijzerman AP, Jacobson KA, Klotz KN, Linden J. 2001. Nomenclature and classification of adenosine receptors. Pharmacol Rev 53:527-552.
10. Graham S, Combes P, Crumiere M, Klotz KN, Dickenson JM. 2001. Regulation of p42/p44 mitogen-activated protein kinase by the human adenosine A3 receptor in transfected CHO cells. Eur J Pharmacol 420:19-26. (Pubitemid 32539091)
11. Heo JS, Han HJ. 2006. ATP stimulates mouse embryonic stem cell proliferation via protein kinase C, phosphatidylinositol 3-kinase/Akt, and mitogen-activated protein kinase signaling pathways. Stem Cells 24:2637-2648.
12. 2+/protein kinase C and epidermal growth factor receptor as well as Gli1 activation. Stem Cells 25:3069-3080.
13. Herlenius E, Lagercrantz H. 2001. Neurotransmitters and neuromodulators during early human development. Early Hum Dev 65:21-37. (Pubitemid 32743368)
14. Isomoto H, Kobayashi S, Werneburg NW. 2005. Interleukin 6 upregulates myeloid cell leukemia-1 expression through a STAT3 pathway in cholangiocarcinoma cells. Hepatology 42:1329-1338. (Pubitemid 43260035)
15. 2 and peroxisome proliferator-activated receptor δ promote mouse embryonic stem cell proliferation. Stem Cells 26:745-755.
16. Lahm T, Crisostomo PR, Markel TA, Wang M, Lillemoe KD, Meldrum DR. 2007. The critical role of vascular endothelial growth factor in pulmonary vascular remodeling after lung injury. Shock 28:4-14. (Pubitemid 46956456)
17. Latini S, Bordini F, Pedata F, Corradertti R. 1999. Extracellular adenosine concentrations during in vitro ischaemia in rat hippocampal slices. Br J Pharmacol 126:729-739. (Pubitemid 29276659)
18. Linden J. 2001. Molecular approach to adenosine receptors: Receptor-mediated mechanisms of tissue protection. Annu Rev Pharmacol Toxicol 41:775-787. (Pubitemid 32385906)
19. Matherne GP, Headrick JP, Coleman SD, Berne RM. 1990. Interstitial transudate purines in normoxic and hypoxic immature and mature rabbit hearts. Pediatr Res 28:348-353. (Pubitemid 20319744)
20. Montaner S, Perona R, Saniger L, Lacal JC. 1998. Multiple signalling pathways lead to the activation of the nuclear factor κB by the Rho family of GTPases. J Biol Chem 273:12779-12785. (Pubitemid 28246832)
21. 2+ mobilization in conjunction with metabotropic glutamate receptor activation by t-ACPD in cultured hippocampal astrocytes. Neurosci Lett Mar 170:5-8.
22. Park J, Tadlock L, Gores GJ, Patel T. 1999. Inhibition of interleukin 6-mediated mitogen-activated protein kinase activation attenuates growth of a cholangiocarcinoma cell line. Hepatology 30:1128-1133. (Pubitemid 29510848)
23. Rashtchian A. 1995. Novel methods for cloning and engineering genes using the polymerase chain reaction. Curr Opin Biotechnol 6:30-36.
24. 2b adenosine receptors coupled to PKC and p38 MAPK. Br J Pharmacol 140:764-772.
25. 3 receptor expressed in Chinese hamster ovary cells to the extracellular signal-regulated kinase 1/2. Mol Pharmacol 62:1137-1146.
26. Schwaninger M, Petersen N, Prinz S, Sallmann S, Neher M, Spranger M. 2000. Adenosine-induced expression of interleukin-6 in astrocytes through protein kinase A and NF-IL-6. Glia 31:51-58. (Pubitemid 30410873)
27. Smith C, Day PJ, Walker MR. 1993. Generation of cohesive ends on PCR products by UDG-mediated excision of dU, and application for cloning into restriction digest-linearized vectors. PCR Methods 2:328-332. (Pubitemid 23298974)
28. Van BH, Goosens F, Wynants J. 1987. Formation and release of purine catabolites during hypoperfusion, anoxia and ischemia. Am J Physiol 252:886-893. (Pubitemid 17080701)
29. Vanden Berghe W, De Bosscher K, Boone E, Plaisance S, Haegeman G. 1999. The nuclear factor-κB engages CBP/p300 and histone acetyltransferase activity for transcriptional activation of the interleukin-6 gene promoter. J Biol Chem 274:32091-32098. (Pubitemid 129503803)
30. Williams LM, Lali F, Willetts K, Balague C, Godessart N, Brennan F, Feldmann M, Foxwell BM. 2008. Rac mediates TNF-induced cytokine production via modulation of NF-κB. Mol Immunol 45:2446-2454.
31. Yaar R, Jones MR, Chen JF, Ravid K. 2005. Animal models for the study of adenosine receptor function. J Cell Physiol 202:9-20. (Pubitemid 39603358)
32. 2b receptor in Xenopus oocytes. Mol Pharmacol 43:277-280.
33. Yamagiwa Y, Marienfeld C, Meng F, Holcik M, Patel T. 2004. Translational regulation of x-linked inhibitor of apoptosis protein by interleukin-6: A novel mechanism of tumor cell survival. Cancer Res 64:1293-1298. (Pubitemid 38235596)
34. Yokomuro S, Tsuji H, Lunz JG. 2000. Growth control of human biliary epithelial cells by interleukin 6, hepatocyte growth factor, transforming growth factor β1, and activin A: Comparison of a cholangiocarcinoma cell line with primary cultures of non-neoplastic biliary epithelial cells. Hepatology 32:26-35. (Pubitemid 30432362)
35. Zhao Z, Yaar R, Ladd D, Cataldo LM, Ravid K. 2002. Overexpression of A3 adenosine receptors in smooth, cardiac, and skeletal muscle is lethal to embryos. Microvasc Res 63:61-69. (Pubitemid 34971509)